| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 54 | 11.905 | 17.317 | 51.850 | 152.498 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -54 | -11.905 | -17.317 | -51.850 | -152.498 |
| Net Profit/Loss - EUR | - | - | - | - | - | -54 | -11.905 | -17.317 | -51.850 | -152.498 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Spitosan Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 2.068 | 993 | 1.282 | 13.192 | 30.998 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 957 | 9.167 | 27.489 |
| Cash | - | - | - | - | - | 2.068 | 993 | 325 | 4.025 | 3.509 |
| Shareholders Funds | - | - | - | - | - | 2.014 | -9.936 | -27.283 | -79.050 | -231.106 |
| Social Capital | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | 54 | 10.928 | 30.086 | 94.870 | 262.105 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8210 - 8210" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Spitosan Med S.r.l.